A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines.

A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines.

Outbreaks of the highly pathogenic avian influenza H5N1 and H7N9 viruses have spurred an unprecedented research effort to develop antivirals and vaccines against influenza. Standardized methods for vaccine evaluation are critical for facilitating vaccine development. Compared with hemagglutination i...

Full description

Bibliographic Details
Main Authors:	Hui Zhao, Kangwei Xu, Zheng Jiang, Ming Shao, Shuzhen Liu, Xuguang Li, Junzhi Wang, Changgui Li
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2018-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC6237356?pdf=render

Similar Items

Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines
by: Kangwei Xu, et al.
Published: (2018-01-01)

Microneutralization reaction compared to hemagglutination inhibition assay to evaluate immunogenicity of influenza vaccines and influenza diagnostics
by: V. Z. Krivitskaya, et al.
Published: (2020-02-01)

Microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children.
by: Chris P Verschoor, et al.
Published: (2015-01-01)

Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay
by: M. S. Camacho-Lovillo, et al.
Published: (2017-08-01)

Evaluation of immunogenicity of the 2008-2009 seasonal influenza vaccines by microneutralization test
by: Seung Youn Kim, et al.
Published: (2012-12-01)

Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans
by: Rijal, P, et al.
Published: (2019)

SARS-CoV-2-Neutralizing Antibody Response and Correlation of Two Serological Assays with Microneutralization
by: Amal Souiri, et al.
Published: (2023-03-01)

Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection
by: Fei-Fei Xiong, et al.
Published: (2020-01-01)

Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers
by: Lena Hansen, et al.
Published: (2021-10-01)

The Comparison of Sensitivity and Specificity of ELISA-based Microneutralization Test with Hemagglutination Inhibition Test to Evaluate Neutralizing Antibody against Influenza Virus (H1N1)
by: Ahmad TAVAKOLI, et al.
Published: (2017-11-01)

A high throughput reporter virus particle microneutralization assay for quantitation of Zika virus neutralizing antibodies in multiple species.
by: Kelly Bohning, et al.
Published: (2021-01-01)

Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines
by: Yulia Desheva, et al.
Published: (2020-05-01)

The Human Antibody Response to the Influenza Virus Neuraminidase Following Infection or Vaccination
by: Madhusudan Rajendran, et al.
Published: (2021-08-01)

Differential recognition of influenza A virus H1N1 neuraminidase by DNA vaccine-induced antibodies in pigs and ferrets
by: Jeanette Linnea Tingstedt, et al.
Published: (2023-05-01)

Heterotypic Neuraminidase Antibodies Against Different A(H1N1) Strains are Elicited after Seasonal Influenza Vaccination
by: Jose Manuel Mendez-Legaza, et al.
Published: (2019-03-01)

Generation of a recombinant chickenized monoclonal antibody against the neuraminidase of H9N2 avian influenza virus
by: Fei Wang, et al.
Published: (2020-08-01)

Study of Antibodies to Influenza Neuraminidase N2
by: Yulia Desheva, et al.
Published: (2022-04-01)

Biological Characterizations of H5Nx Avian Influenza Viruses Embodying Different Neuraminidases
by: Yuandi Yu, et al.
Published: (2017-06-01)

Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.
by: Don Changsom, et al.
Published: (2016-01-01)

Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals.
by: Yulia Desheva, et al.
Published: (2018-01-01)

Antigenic Characterization of Neuraminidase of Influenza A/H7N9 Viruses Isolated in Different Years
by: Yulia Desheva, et al.
Published: (2022-09-01)

A simple and safe antibody neutralization assay based on polio pseudoviruses
by: Zheng Jiang, et al.
Published: (2019-02-01)

Prokaryotic Expression of the Influenza A (H5N1) Neuraminidase
by: Zahra Latif, et al.
Published: (2021-04-01)

Avian Influenza A(H5N1) Neuraminidase Inhibition Antibodies in Healthy Adults after Exposure to Influenza A(H1N1)pdm09
by: Pavithra Daulagala, et al.
Published: (2024-01-01)

Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America.
by: Lindsay N Carpp, et al.
Published: (2020-01-01)

A novel synthetic receptor-based immunoassay for influenza vaccine quantification.
by: Anwar M Hashem, et al.
Published: (2013-01-01)

Serum anti-neuraminidase antibody responses in human influenza A(H1N1)pdm09 virus infections
by: Herath M. T. K. Karunarathna, et al.
Published: (2019-01-01)

The use of an <it>in vitro </it>microneutralization assay to evaluate the potential of recombinant VP5 protein as an antigen for vaccinating against Grass carp reovirus
by: Xu Dan, et al.
Published: (2011-03-01)

Effectiveness of neuraminidase inhibitors to prevent mortality in patients with laboratory-confirmed avian influenza A H7N9
by: Wei Cheng, et al.
Published: (2021-02-01)

Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines
by: Mariia V. Sergeeva, et al.
Published: (2023-11-01)

Positive selection on hemagglutinin and neuraminidase genes of H1N1 influenza viruses
by: Luo Arong, et al.
Published: (2011-04-01)

Mutational fitness landscape of human influenza H3N2 neuraminidase
by: Ruipeng Lei, et al.
Published: (2023-10-01)

Mutational fitness landscape of human influenza H3N2 neuraminidase
by: Ruipeng Lei, et al.
Published: (2023-01-01)

An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study
by: Joanna Waldock, et al.
Published: (2023-02-01)

Broadly Protective Neuraminidase-Based Influenza Vaccines and Monoclonal Antibodies: Target Epitopes and Mechanisms of Action
by: Nada Abbadi, et al.
Published: (2023-01-01)

Influenza Neuraminidase Characteristics and Potential as a Vaccine Target
by: Sarah Creytens, et al.
Published: (2021-11-01)

Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays
by: Jenni Virtanen, et al.
Published: (2021-05-01)

Antibody Neutralization of an Influenza Virus that Uses Neuraminidase for Receptor Binding
by: Lauren E. Gentles, et al.
Published: (2020-05-01)

Monoclonal antibodies targeting the influenza virus N6 neuraminidase
by: Shirin Strohmeier, et al.
Published: (2022-07-01)

Evaluation of Commercial Diagnostic Assays for the Specific Detection of Avian Influenza A (H7N9) Virus RNA Using a Quality-Control Panel and Clinical Specimens in China.
by: Dawei Shi, et al.
Published: (2015-01-01)